<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-LD6UWK21/c0d3218a-5b25-4038-b97b-fb028ea75ead/PDF"><dcterms:extent>106 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-LD6UWK21/916b223c-7d5f-4546-b36f-cf3bafce9d32/TEXT"><dcterms:extent>0 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-LD6UWK21"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>2003</dcterms:issued><dc:creator>Kansky, Aleksej</dc:creator><dc:format xml:lang="sl">letnik:12</dc:format><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 143-150</dc:format><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>COBISSID:17456345</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-LD6UWK21</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="en">Adverse Drug Reaction Reporting Systems</dc:subject><dc:subject xml:lang="en">Adverse Effects</dc:subject><dc:subject xml:lang="sl">alergije</dc:subject><dc:subject xml:lang="sl">dermatologija</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="en">drug</dc:subject><dc:subject xml:lang="en">Drug Eruptions</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="en">Drug Utilization</dc:subject><dc:subject xml:lang="en">Physiopathology</dc:subject><dc:subject xml:lang="sl">Škodljivi učinki zdravila, poročanje, sistemi</dc:subject><dc:subject xml:lang="sl">zdravila</dc:subject><dc:subject xml:lang="sl">Zdravilo, izpuščaji</dc:subject><dc:subject xml:lang="sl">Zdravilo, uporaba</dc:subject><dc:subject xml:lang="sl">Zdravljenje z zdravili</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Excessive use of drugs and adverse events| epidemiologic and pathogenetic aspects|</dc:title><dc:description xml:lang="sl">Background. An unwarranted increase in the prescription and intake of drugs can be observed in the developed countries. The data on the incidence of adverse drug events is not reliable, but estimated to be close to 10%. Most drug eruptions affect the skin and are not life-threatening, but some very serious adverse drug events also occur. The cost of the drugs themselves, as well as the treatments, are becoming a burden on both insurance company and state budgets. Underlying causes of the excessive use of drugs. Information about drug usage may be partially biased. One effect of intensive and costly research has been to increase the supply of drugs. Articles in the popular press, advertising and also the sponsorship of congresses and symposia by drugmanufacturers may also be seen as contributing to the awareness of and excessive use of drugs. Those involved in the misuse of drugs are frequently those most highly affected by the stress of modern life, psychopathic personalities, and drug addicts. Mechanisms by which adverse drug events are provoked. Allergic, non-allergic and pharmacogenetic mechanisms as well as drug overuse, toxic effects and the incompatibility of different drugs taken together are the most frequent trigger factors. Means by which the number of adverse drug events may be reduced. Adverse drug events may be reduced given the dissemination of correct information, through controlled clinical studies,through a strict editorial policy by the editors of medical journals, through an epidemiological approach to the phenomenon of adverse drug events, through pharmacogenetic studies, through appropriate reaction to biased data, and through general education in the sense of making the patient more aware and more careful of their psychic and physical condition</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-LD6UWK21"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-LD6UWK21" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-LD6UWK21/c0d3218a-5b25-4038-b97b-fb028ea75ead/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-LD6UWK21/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-LD6UWK21" /></ore:Aggregation></rdf:RDF>